The Patent Finder

Cyrano Therapeutics, Inc.

Also on record
Records under this name other than the patents Cyrano Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.

Showing 1 to 6 of 6 · Back to Cyrano Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,670,849Method for diagnosing insulin resistance from nasal secretions
Term ended
Term ended May 1, 2026 · USPTO record
Term endedTerm ended May 1, 2026USPTO record
US 8,968,706Methods for Diagnosing and Treating Loss or Distortion of Taste
Term ended
Term ended May 1, 2026 · Medium confidence
Term endedTerm ended May 1, 2026Medium confidence
US 10,206,927Compostions and methods for treating chemosensory dysfunction
Term ended
Ended no later than May 1, 2026 · USPTO record
Term endedEnded no later than May 1, 2026USPTO record
US 11,389,453Compositions and methods for treating chemosensory dysfunction
Term ended
Ended no later than May 1, 2026 · USPTO record
Term endedEnded no later than May 1, 2026USPTO record
US 8,663,938Methods for detection of biological substances
Lapsed on the fee record
Ended Mar 4, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 4, 2026USPTO record
US 8,506,934Methods for detection of biological substances
Lapsed on the fee record
Ended Aug 13, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 13, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited